Navigation Links
Advantages of Singapore as a Clinical Supply Hub to be Discussed by Catalent at Accelerating Clinical Trials in Asia Conference
Date:9/17/2019

Catalent, a global leader in clinical supply services, today announced that Julie Delaney, Director, Project and Clinical Supplies Management, Asia Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials in Asia, at the One Farrer Hotel, Singapore, on Sept. 25-26, 2019.

On Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney will present “Singapore: APAC’s Clinical Supply Gateway to the World.” She will explain the economic and regulatory advantages of locating a clinical supply hub in Singapore and will also discuss the importance of clinical supply management in optimizing drug development and launch strategy, ensuring trials are executed on time.

Ms. Delaney has more than 25 years’ experience in clinical supplies management, with over 10 years spent in the APAC region. She has held several roles in supplies management and quality assurance for several pharmaceutical companies and contract manufacturing organizations. In her current role, Ms. Delaney is responsible for Catalent’s project management teams in Singapore, China and Japan.

For further information, visit http://www.clinical.catalent.com/events/accelerating-clinical-trials-in-asia-ibc.

About Catalent
Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs nearly 13,000 people, including approximately 2,400 scientists, at more than 35 facilities across five continents, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

Read the full story at https://www.prweb.com/releases/advantages_of_singapore_as_a_clinical_supply_hub_to_be_discussed_by_catalent_at_accelerating_clinical_trials_in_asia_conference/prweb16576861.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Advantages of Piezoelectric Actuators in Haptic Feedback
2. Bruce Wiley Joins the Executive Team at FamilyFarms Group as Managing Director of Competitive Advantages
3. New Charm Peel Plate EC Offers Significant Advantages in Traditional Coliform Count Testing — Awarded AOAC-RI Performance Test Method Status
4. New England Biolabs opens seventh subsidiary in Singapore
5. RAPS Opens Offices in Singapore and China
6. Singapore Focus Chemistry Launches New Website, Www.FocusChemistry.Com, Targeting A Level Chemistry Students
7. Nanotechnology experts to gather in Singapore for 3rd Nano Today Conference
8. Singaporean university launches worlds 1st ZigBee-based inter-satellite comms system
9. NTU Singapore lights up photonics research with $100 million institute
10. Global Stem Cells Group Announces Agreement with Singapore Stem Cell Training Network
11. Healy Consultants Releases New Singapore Incorporation Guide for Foreigners as the Country Transformed into a Strong Digital Hub & a Launch Pad for New Emerging Economies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2019)... , ... October 09, 2019 , ... ... Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for ... 2019 in Las Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative ...
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has ... October 18-19th, 2019 in Las Vegas with spots still open. , The speaker, Dr. ... several Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as the ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... Madhumita Suresh and Leslie Maurer presented company executives with a set of recommendations ... (MBS) graduates will offer insights from their TMP to a wider audience of ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell biotechnology company ... technology. Like the company’s precursor patent, approved in the U.S. in 2017, the ... stem cells. Asymmetrex now markets the technology in the U.S. as the AlphaSTEM ...
Breaking Biology Technology:
(Date:10/10/2019)... ... October 10, 2019 , ... ... ultrasound, invites attendees of the American Society of Anesthesiologists 2019 Annual Meeting to ... on October 19-21 in Orlando, Florida, and will provide more than 14,000 healthcare ...
(Date:10/8/2019)... (PRWEB) , ... October 07, 2019 , ... The future ... to the genetic level, resulting in people living longer, healthier lives. But it will ... on earth. , Leroy E. Hood, MD, PhD, Chief Strategy Officer and Co-Founder of ...
(Date:10/3/2019)... ... October 02, 2019 , ... Personalized Stem Cells, ... patient in an FDA approved clinical trial for stem cell treatment of knee ... formation of the company as a subsidiary of VetStem Biopharma. , PSC CEO, Michael ...
Breaking Biology News(10 mins):